Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(21 sites)
United States
Stanford Cancer Institute, Stanford, California University of Colorado, Anschutz Medical Campus, Aurora, Colorado University of Miami Hospital and Clinics, Miami, Florida University of Chicago Medical Center, Chicago, Illinois Massachusetts General Hospital, Boston, Massachusetts